Financhill
Back

Cytokinetics Stock Predictions

Cytokinetics Stock Forecast

  • Over the next 52 weeks, Cytokinetics has on average historically risen by 12.1% based on the past 20 years of stock performance.
  • Cytokinetics has risen higher in 8 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
  • Is Cytokinetics Stock Undervalued?
    The current Cytokinetics [CYTK] share price is $54.70. The Score for CYTK is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • CYTK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Cytokinetics Stock Go Up Next Year?

  • Over the next 52 weeks, Cytokinetics has on average historically risen by 12.1% based on the past 20 years of stock performance.

Cytokinetics Stock Rating

Buy
53
Cytokinetics (CYTK) is a Buy

Is Cytokinetics overpriced?

  • Cytokinetics has risen higher in 8 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%

Cytokinetics Stock Price History

Is CYTK stock going to rise?

  • The current trend is moderately bullish and CYTK is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cytokinetics.com

52-Week Data

52-Week High:
110.25
52-Week Low:
30.68

Prediction Charts

Market Cap:
6.46B
Price in USD:
54.70
Volume:
896.05K
Beta:
1.44

Technical Analysis

SMA50:
54.19
SMA100:
55.12
SMA200:
60.40
52-Wk Change:
59.52%

Stock Predictions

  • Is Cytokinetics stock public?
    Yes, Cytokinetics is a publicly traded company.
  • What is the Cytokinetics stock quote today?
    The Cytokinetics stock price is 54.70 USD today.
  • How to buy Cytokinetics stock online?
    You can buy Cytokinetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-28 52.25 52.26 53.32 52.04
Oct-29 51.92 51.51 52.24 51.19
Oct-30 50.93 51.37 52.07 50.93
Oct-31 51.04 51.05 51.47 50.53
Nov-1 51.61 51.82 52.37 51.02
Nov-4 51.35 51.48 52.10 50.97
Nov-5 51.31 52.52 53.00 50.88
Nov-6 53.99 55.50 55.68 53.19
Nov-7 54.99 55.84 57.48 54.63
Nov-8 56.31 57.98 58.74 56.10
Nov-11 59.31 58.62 59.39 57.80
Nov-12 58.33 56.21 58.95 56.08
Nov-13 56.79 55.95 57.75 55.95
Nov-14 55.74 54.70 56.31 54.56

Cytokinetics Earnings

Cytokinetics Earnings Report: Per Share Cytokinetics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Cytokinetics Forecast Revenue Growth

Cytokinetics Stock Analysis: Historical quarterly revenues per share for Cytokinetics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and an increase next year of $0.11 per share.

* Cytokinetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.